245 related articles for article (PubMed ID: 15058092)
1. [Current situation of substance abuse/dependence in psychiatric hospital settings].
Ozaki S
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Feb; 39(1):35-40. PubMed ID: 15058092
[TBL] [Abstract][Full Text] [Related]
2. [Current situation and clinical characteristics of sedative-related disorder patients in Japan: a comparison with methamphetamine-related disorder patients].
Matsumoto T; Ozaki S; Kobayashi O; Wada K
Seishin Shinkeigaku Zasshi; 2011; 113(12):1184-98. PubMed ID: 22352004
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
[TBL] [Abstract][Full Text] [Related]
4. [Inhalant abusers and psychiatric symptoms].
Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
Weich L; Pienaar W
Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
[TBL] [Abstract][Full Text] [Related]
7. Recent changes in the clinical features of patients with new psychoactive-substances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014.
Matsumoto T; Tachimori H; Takano A; Tanibuchi Y; Funada D; Wada K
Psychiatry Clin Neurosci; 2016 Dec; 70(12):560-566. PubMed ID: 27527499
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of patients with designer-drug-related disorder in Japan: a comparison with patients with methamphetamine- and hypnotic/anxiolytic-related disorders.
Matsumoto T; Tachimori H; Tanibuchi Y; Takano A; Wada K
Psychiatry Clin Neurosci; 2014 May; 68(5):374-82. PubMed ID: 24405505
[TBL] [Abstract][Full Text] [Related]
9. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
10. [A clinical study of substance dependence patients combined with other psychiatric disorders].
Kuwata T; Suwaki H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Oct; 33(5):574-86. PubMed ID: 9844377
[TBL] [Abstract][Full Text] [Related]
11. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: a retrospective study.
Tang AK; Tang WK; Liang HJ; Chan F; Mak SC; Ungvari GS
East Asian Arch Psychiatry; 2012 Dec; 22(4):154-9. PubMed ID: 23271584
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of recent methamphetamine abusers: comparison between smoking abusers and injection abusers].
Matsumoto T
Seishin Shinkeigaku Zasshi; 2000; 102(5):498-513. PubMed ID: 10897680
[TBL] [Abstract][Full Text] [Related]
14. [What is the Japanese mental health service lacking for drug dependence rehabilitation?].
Matsumoto T; Kobayashi O
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):172-87. PubMed ID: 18646643
[TBL] [Abstract][Full Text] [Related]
15. [Current situation of and the political measures for drug abuse/dependence].
Wada K; Ozaki S; Kondo A
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Apr; 43(2):120-31. PubMed ID: 18516951
[TBL] [Abstract][Full Text] [Related]
16. [Psychotic disorders and drug abuse in adolescents].
Fleischhaker C; Priemer K; Schulz E; Remschmidt H
Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):87-95. PubMed ID: 12053878
[TBL] [Abstract][Full Text] [Related]
17. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
Møller T; Linaker OM
Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration.
Matsumoto T; Kamijo A; Miyakawa T; Endo K; Yabana T; Kishimoto H; Okudaira K; Iseki E; Sakai T; Kosaka K
Addiction; 2002 Jul; 97(7):809-17. PubMed ID: 12133119
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
